Episode 85: Covid-19 vaccine rollout across Europe - a podcast by Hear what our experts are saying

Europe and the UK have experienced an uneven rollout of vaccines. In today’s episode, our country risk and life science experts come together to talk about supply chain challenges, heightened protectionist moments, enhanced regulatory reviews, and even strange vaccine bedfellows as some countries turn to Russia’s Sputnik vaccine to push along herd immunity.

Lindsay Newman (Moderator), Director, Economics & Country Risk, IHS Markit
https://experts.ihsmarkit.com/experts/newman-lindsay

Eoin Ryan, Senior Analyst, Life Sciences, IHS Markit
https://experts.ihsmarkit.com/experts/ryan-eoin

Diego Iscaro, Senior European Economist, IHS Markit
https://experts.ihsmarkit.com/experts/iscaro-diego

Dijedon Imeri, Senior Country Risk Analyst, IHS Markit
https://experts.ihsmarkit.com/experts/imeri-dijedon

Learn more additional risk to vaccine rollouts:
Vaccine hesitancy boosts risks from vaccine nationalism
https://ihsmarkit.com/research-analysis/vaccine-hesitancy-boosts-risks-from-vaccine-nationalism.html

The risks of vaccine nationalism
https://ihsmarkit.com/research-analysis/the-risk-of-vaccine-nationalism.html

Further episodes of IHS Markit | Economics & Country Risk

Further podcasts by Hear what our experts are saying

Website of Hear what our experts are saying